Hubei Zhongyi Science Technology (301150) Fundamentals 2026 — P/E 62.3x, Revenue Analysis | SniperIQ
Hubei Zhongyi Science Technology (301150) is a CN-listed Industrials company in Electrical Equipment & Parts with a market capitalization of ¥11.7B, trading at ¥36.19 on the SHZ. This SniperIQ fundamentals page covers Hubei Zhongyi Science Technology's valuation (P/E 62.3x, P/B 2.3x), profitability (net margin 2.2%), revenue (¥5.9B in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is Hubei Zhongyi Science Technology's market cap?
Hubei Zhongyi Science Technology (301150) has a market capitalization of approximately ¥11.7B, trading at ¥36.19 on the SHZ. Market cap moves with the live share price.
What is Hubei Zhongyi Science Technology's P/E ratio?
Hubei Zhongyi Science Technology's trailing twelve-month P/E ratio is 62.3x, with a price-to-book (P/B) of 2.3x. Valuation multiples are best compared with Industrials sector peers rather than read in isolation.
How profitable is Hubei Zhongyi Science Technology?
Hubei Zhongyi Science Technology runs a net profit margin of 2.2%, a gross margin of 7.1%, and an operating margin of 2.1%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Hubei Zhongyi Science Technology generate?
Hubei Zhongyi Science Technology reported revenue of ¥5.9B for fiscal year 2025, with net income of ¥65M and earnings per share (EPS) of 0.28. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does Hubei Zhongyi Science Technology pay a dividend?
Hubei Zhongyi Science Technology offers a trailing dividend yield of about 0.8%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.
Is Hubei Zhongyi Science Technology financially healthy?
Hubei Zhongyi Science Technology carries a debt-to-equity ratio of 0.16x and a current ratio of 1.63x, with a market beta of 0.65. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Hubei Zhongyi Science Technology a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Hubei Zhongyi Science Technology (301150) the key facts are: market cap ¥11.7B, P/E 62.3x, revenue ¥5.9B, 52-week range 15.32143-72.24. Weigh valuation, profitability, growth, and balance-sheet strength against Industrials peers and form your own view.
Track Hubei Zhongyi Science Technology's full fundamentals live
Get Hubei Zhongyi Science Technology's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.